Clinical Trials

50 enrolled

Tumor-Agnostic

Neoplasms

NCT05179408 2026-01-27

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

40 enrolled

Lung Neoplasms

NCT05467748 2026-01-27

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Phase 1/2 Recruiting

66 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07351019 2026-01-20

Colonoscopy Bowel Prep Comparison Among Diabetic Patients

Phase 4 Recruiting

80 enrolled

Colon Cancer Screening

NCT05926102 2026-01-13

ProGRESS

5,000 enrolled

Genetic Risk Score, Prostatic Neoplasms

NCT06084338 2025-12-31

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

60 enrolled

Prostatic Neoplasms

NCT06778434 2025-12-22

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

48 enrolled

Dermatologic

Keratosis, Actinic

NCT06671613 2025-11-10

Stage IV NSCLC

66 enrolled

Carcinoma, Non-Small-Cell Lung, Fasting

NCT05563766 2025-11-05

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

78 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

NCT06520098 2025-10-14

Benefit VA

LymphoidOther hematologic neoplasm

100 enrolled

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06432985 2025-09-30

CM_TUD_Cancer

108 enrolled

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

NCT05519241 2025-09-02

A Phase I Intravesical PPM Therapy for NMIBC

Phase 1 Recruiting

29 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04038502 2025-08-20

COBRA

Classical hematologyGenitourinary

100 enrolled

Fanconi Anemia, Complementation Group N, Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

NCT06825715 2025-08-01

MIPO

2,653 enrolled

Advanced Cancers of the Prostate

NCT07019844 2025-07-23

PSMA PET for the Staging and Management of Hepatocellular Carcinoma

Recruiting

90 enrolled

Carcinoma, Hepatocellular

NCT07058571 2025-07-10

Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention

Other hematologic neoplasm

30 enrolled

Motor Activity, Hematologic Neoplasms

NCT05011383 2025-07-09

VA-BAT

51 enrolled

Prostatic Neoplasms

NCT06746623 2025-06-05

Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux

400 enrolled

Barrett Esophagus, Tobacco Use

NCT06706921 2024-11-27

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Phase 4 Recruiting

15 enrolled

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT06252662 2024-11-19

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

Phase 4 Recruiting

200 enrolled

Breast

Breast Neoplasms, Pain, Postoperative

NCT05430009 2022-08-01

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

Phase 1 Recruiting

12 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03753243 2022-04-20

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

32 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04018872 2021-11-04

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

78 enrolled